Mehow Innovative

Mehow Innovative EBIT CAGR 5Y

The EBIT CAGR (5 Year) of Mehow Innovative (301363.SZ) as of Oct 29, 2026 is 1.19 %. In the previous year, EBIT CAGR (5 Year) was 1.19 % — a change of 0.00% (lower).

EBIT CAGR 5Y

1.19 %

YoY

0.00%

Last updated:

EBIT CAGR (5 Year) of Mehow Innovative is 2025 1.19 % . EBIT CAGR (5 Year) of Mehow Innovative was 2024 1.19 % . It decreases by 0.00% lower compared to the previous year.

The Mehow Innovative EBIT CAGR 5Y history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT CAGR 5Y
Date
EBIT CAGR 5Y
Jan 1, 2019
1.19 CNY
Jan 1, 2020
1.19 CNY
Jan 1, 2021
1.19 CNY
Jan 1, 2022
1.19 CNY
Jan 1, 2023
1.19 CNY
Jan 1, 2024
1.19 CNY
Jan 1, 2025
1.19 CNY
The Mehow Innovative EBIT CAGR 5Y history
YEAREBIT CAGR 5YYoY
1.19 %0.00%
1.19 %0.00%
1.19 %0.00%
1.19 %0.00%
1.19 %0.00%
1.19 %0.00%
1.19 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Mehow Innovative Stock analysis

What does Mehow Innovative do? Mehow Innovative Ltd. generates revenue through the design, development, manufacturing, and services of medical equipment. The company offers full-process services from product design and development to mass production and delivery for domestic and foreign medical device customers. Its main products include home ventilator components, precision molds and automation equipment, cochlear implant components, and spirometers. These components are primarily used in the production of household ventilators and cochlear implant products. The firm distributes its products in both domestic and overseas markets, serving medical device manufacturers and healthcare providers who require specialized equipment and components for their production processes. Mehow Innovative Ltd. focuses on providing comprehensive solutions for medical device manufacturers, including home ventilator components and cochlear implant components. The company's precision molds and automation equipment support the manufacturing of various medical devices, while spirometers are offered as standalone medical device products. Domestic and overseas markets represent key segments for the company's product distribution, with a particular emphasis on serving clients involved in the production of ventilators and cochlear implants. The firm's services extend from initial design to final delivery, ensuring end-to-end support for its customers' medical device needs. The company's revenue streams are derived from the sale of home ventilator components, precision molds, automation equipment, cochlear implant components, and spirometers. These products cater to the needs of medical device manufacturers who require specialized components for household ventilators and cochlear implant systems. By offering full-process services, Mehow Innovative Ltd. positions itself as a key supplier in the medical equipment sector, serving both domestic and international clients across multiple market segments. Mehow Innovative is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Mehow Innovative stock

EBIT CAGR (5 Year) of Mehow Innovative is 1.19 % in 2025.

On Eulerpool you can find the complete historical development of EBIT CAGR (5 Year) Mehow Innovative since 2006 – with annual values, charts, and detailed analysis.

The 5-year EBIT CAGR shows the compound annual growth rate of EBIT over the past five years.

To evaluate EBIT CAGR (5 Year)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EBIT CAGR (5 Year).

EBIT CAGR (5 Year)'s is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBIT CAGR (5 Year)'s Mehow Innovative historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Growth — Mehow Innovative

All Key Metrics — Mehow Innovative